{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:30:06Z","timestamp":1792009806120,"version":"4.4.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T00:00:00Z","timestamp":1641945600000},"content-version":"vor","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.immuni.2020.11.002","type":"journal-article","created":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T10:48:35Z","timestamp":1606906115000},"page":"116-131.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":138,"title":["Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas"],"prefix":"10.1016","volume":"54","author":[{"given":"Devin","family":"Dersh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Phelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Gumina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse H.","family":"Arbuckle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav","family":"Holly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rigel J.","family":"Kishton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tovah E.","family":"Markowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina O.","family":"Seedhom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Fridlyand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George W.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Ceribelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin B.","family":"Lack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P.","family":"Restifo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Kristie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis M.","family":"Staudt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan W.","family":"Yewdell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2020.11.002_bib1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2020.11.002_bib2","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41586-019-1671-8","article-title":"MHC-II neoantigens shape tumour immunity and response to immunotherapy","volume":"574","author":"Alspach","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2020.11.002_bib3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1200\/JCO.18.00766","article-title":"Nivolumab for Relapsed\/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study","volume":"37","author":"Ansell","year":"2019","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.immuni.2020.11.002_bib4","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol."},{"key":"10.1016\/j.immuni.2020.11.002_bib5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0022-3565(24)29405-2","article-title":"Tumor growth inhibition in\u00a0vivo and G2\/M cell cycle arrest induced by antisense oligodeoxynucleotide targeting thymidylate synthase","volume":"298","author":"Berg","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.immuni.2020.11.002_bib6","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1073\/pnas.1222342110","article-title":"Tapasin-related protein TAPBPR is an additional component of the MHC class I presentation pathway","volume":"110","author":"Boyle","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2020.11.002_bib7","doi-asserted-by":"crossref","first-page":"5065","DOI":"10.18632\/oncotarget.2080","article-title":"Mutational analysis of primary central nervous system lymphoma","volume":"5","author":"Bruno","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.immuni.2020.11.002_bib8","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1182\/blood-2016-09-741348","article-title":"Impairment of both IRE1 expression and XBP1 activation is a hallmark of GCB DLBCL and contributes to tumor growth","volume":"129","author":"Bujisic","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2020.11.002_bib9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ccell.2019.08.008","article-title":"An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer","volume":"36","author":"Burr","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2020.11.002_bib10","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1172\/JCI70626","article-title":"Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis","volume":"123","author":"Caganova","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.immuni.2020.11.002_bib11","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1038\/ncomms4127","article-title":"The central role of EED in the orchestration of polycomb group complexes","volume":"5","author":"Cao","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2020.11.002_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.immuni.2020.11.002_bib13","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","article-title":"Combined genetic inactivation of \u03b22-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma","volume":"20","author":"Challa-Malladi","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2020.11.002_bib14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2020.11.002_bib15","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"The GTEx Consortium atlas of genetic regulatory effects across human tissues","volume":"369","author":"Consortium","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.immuni.2020.11.002_bib16","series-title":"Most Non-Canonical Proteins Uniquely Populate the Proteome or Immunopeptidome. Available at SSRN","author":"Cuevas","year":"2020"},{"key":"10.1016\/j.immuni.2020.11.002_bib17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cell.2010.03.040","article-title":"NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways","volume":"141","author":"Cui","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2020.11.002_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-020-00445-3","article-title":"A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion","author":"Dersh","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.immuni.2020.11.002_bib19","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2007-04-087734","article-title":"Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas","volume":"111","author":"Ding","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2020.11.002_bib20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.immuni.2020.11.002_bib21","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.4049\/jimmunol.177.9.6018","article-title":"Dendritic cells cross-dressed with peptide MHC class I complexes prime CD8+ T\u00a0cells","volume":"177","author":"Dolan","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2020.11.002_bib22","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nature10688","article-title":"FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas","volume":"481","author":"Duan","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2020.11.002_bib23","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ccell.2020.06.002","article-title":"Immunogenomic Landscape of Hematological Malignancies","volume":"38","author":"Dufva","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2020.11.002_bib24","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2159-8290.CD-18-1090","article-title":"Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition","volume":"9","author":"Ennishi","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.immuni.2020.11.002_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2164-12-42","article-title":"Next-generation sequencing for HLA typing of class I loci","volume":"12","author":"Erlich","year":"2011","journal-title":"BMC Genomics"},{"key":"10.1016\/j.immuni.2020.11.002_bib26","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/bjc.1990.437","article-title":"Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx","volume":"62","author":"Esteban","year":"1990","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.immuni.2020.11.002_bib27","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","article-title":"MultiQC: summarize analysis results for multiple tools and samples in a single report","volume":"32","author":"Ewels","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.immuni.2020.11.002_bib28","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1128\/MCB.01362-12","article-title":"Degradation of newly synthesized polypeptides by ribosome-associated RACK1\/c-Jun N-terminal kinase\/eukaryotic elongation factor 1A2 complex","volume":"33","author":"Gandin","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.immuni.2020.11.002_bib29","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.immuni.2020.11.002_bib30","doi-asserted-by":"crossref","first-page":"E1116","DOI":"10.1073\/pnas.1501199112","article-title":"Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation","volume":"112","author":"Green","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2020.11.002_bib31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cell.2019.08.012","article-title":"Proteomics of Melanoma Response to Immunotherapy Reveals Mitochondrial Dependence","volume":"179","author":"Harel","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2020.11.002_bib32","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/179663a0","article-title":"Fluorinated pyrimidines, a new class of tumour-inhibitory compounds","volume":"179","author":"Heidelberger","year":"1957","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2020.11.002_bib33","first-page":"237","article-title":"Studies on isoantigenic variation in mouse lymphomas","volume":"25","author":"Hellstrom","year":"1960","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.immuni.2020.11.002_bib34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7554\/eLife.09617","article-title":"TAPBPR alters MHC class I peptide presentation by functioning as a peptide exchange catalyst","volume":"4","author":"Hermann","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.immuni.2020.11.002_bib35","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer","volume":"173","author":"Hoadley","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2020.11.002_bib36","doi-asserted-by":"crossref","first-page":"18545","DOI":"10.1074\/jbc.M201022200","article-title":"Interaction of the eukaryotic elongation factor 1A with newly synthesized polypeptides","volume":"277","author":"Hotokezaka","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.immuni.2020.11.002_bib37","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1470-2045(18)30145-1","article-title":"Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study","volume":"19","author":"Italiano","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.immuni.2020.11.002_bib38","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1158\/2159-8290.CD-16-0975","article-title":"CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas","volume":"7","author":"Jiang","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.immuni.2020.11.002_bib39","article-title":"The SPPL3-defined glycosphingolipid repertoire orchestrates HLA class I-mediated immune responses","volume":"54","author":"Jongsma","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2020.11.002_bib40","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2020.11.002_bib41","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1101\/gad.1200204","article-title":"Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27","volume":"18","author":"Kirmizis","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.immuni.2020.11.002_bib42","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1038\/bcj.2013.28","article-title":"High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites","volume":"3","author":"Kraan","year":"2013","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.immuni.2020.11.002_bib43","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1182\/blood-2007-09-111948","article-title":"Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-kappaB pathways in subtypes of diffuse large B-cell lymphoma","volume":"111","author":"Lam","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2020.11.002_bib44","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1126\/scitranslmed.aau5516","article-title":"Noncoding regions are the main source of targetable tumor-specific antigens","volume":"10","author":"Laumont","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2020.11.002_bib45","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1200\/JCO.2015.65.9789","article-title":"Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study","volume":"34","author":"Lesokhin","year":"2016","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.immuni.2020.11.002_bib46","doi-asserted-by":"crossref","first-page":"167ra5","DOI":"10.1126\/scitranslmed.3005145","article-title":"Targeting the JMJD2 histone demethylases to epigenetically control herpesvirus infection and reactivation from latency","volume":"5","author":"Liang","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2020.11.002_bib47","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1158\/2326-6066.CIR-18-0424","article-title":"Mapping the MHC Class I-Spliced Immunopeptidome of Cancer Cells","volume":"7","author":"Liepe","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.immuni.2020.11.002_bib48","doi-asserted-by":"crossref","first-page":"E498","DOI":"10.1073\/pnas.1715118115","article-title":"Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma","volume":"115","author":"Lu","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2020.11.002_bib49","doi-asserted-by":"crossref","first-page":"e1005088","DOI":"10.1371\/journal.pgen.1005088","article-title":"NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module","volume":"11","author":"Ludigs","year":"2015","journal-title":"PLoS Genet."},{"key":"10.1016\/j.immuni.2020.11.002_bib50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11899-018-0466-6","article-title":"Emerging EZH2 Inhibitors and Their Application in Lymphoma","volume":"13","author":"Lue","year":"2018","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"10.1016\/j.immuni.2020.11.002_bib51","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/ni1459","article-title":"A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses","volume":"8","author":"Mayor","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.immuni.2020.11.002_bib52","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2020.11.002_bib53","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.cell.2017.10.001","article-title":"Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution","volume":"171","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2020.11.002_bib54","doi-asserted-by":"crossref","first-page":"4951","DOI":"10.4049\/jimmunol.1103160","article-title":"NLRC5 cooperates with the RFX transcription factor complex to induce MHC class I gene expression","volume":"188","author":"Meissner","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.immuni.2020.11.002_bib55","doi-asserted-by":"crossref","first-page":"e1295202","DOI":"10.1080\/2162402X.2017.1295202","article-title":"HLA dependent immune escape mechanisms in B-cell lymphomas: Implications for immune checkpoint inhibitor therapy?","volume":"6","author":"Nijland","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1016\/j.immuni.2020.11.002_bib56","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/cyto.a.23919","article-title":"Single Cell Phenotypic Profiling of 27 DLBCL Cases Reveals Marked Intertumoral and Intratumoral Heterogeneity","volume":"97","author":"Nissen","year":"2020","journal-title":"Cytometry A"},{"key":"10.1016\/j.immuni.2020.11.002_bib57","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.biochi.2015.10.026","article-title":"Translation elongation factor eEF1A1 is a novel partner of a multifunctional protein Sgt1","volume":"119","author":"Novosylna","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.immuni.2020.11.002_bib58","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature23477","article-title":"Identification of essential genes for cancer immunotherapy","volume":"548","author":"Patel","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2020.11.002_bib59","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41586-018-0290-0","article-title":"A multiprotein supercomplex controlling oncogenic signalling in lymphoma","volume":"560","author":"Phelan","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2020.11.002_bib60","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1093\/hmg\/ddv158","article-title":"Epigenetic regulation of differential HLA-A allelic expression levels","volume":"24","author":"Ramsuran","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.immuni.2020.11.002_bib61","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.clml.2014.05.002","article-title":"Evaluating cell-of-origin subtype methods for predicting diffuse large B-cell lymphoma survival: a meta-analysis of gene expression profiling and immunohistochemistry algorithms","volume":"14","author":"Read","year":"2014","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.immuni.2020.11.002_bib62","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1158\/1078-0432.CCR-14-2708","article-title":"A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response","volume":"21","author":"Robbins","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.immuni.2020.11.002_bib63","doi-asserted-by":"crossref","first-page":"D423","DOI":"10.1093\/nar\/gku1161","article-title":"The IPD and IMGT\/HLA database: allele variant databases","volume":"43","author":"Robinson","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2020.11.002_bib64","first-page":"220","article-title":"Thymidylate synthase: a critical target for cancer chemotherapy","volume":"1","author":"Rose","year":"2002","journal-title":"Clin. Colorectal Cancer"},{"key":"10.1016\/j.immuni.2020.11.002_bib65","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2020.11.002_bib66","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41467-017-01062-w","article-title":"Resistance to checkpoint blockade therapy through inactivation of antigen presentation","volume":"8","author":"Sade-Feldman","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2020.11.002_bib67","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.1158\/1078-0432.CCR-19-0433","article-title":"The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer Immunotherapy","volume":"25","author":"Schaer","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.immuni.2020.11.002_bib68","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2020.11.002_bib69","doi-asserted-by":"crossref","first-page":"152","DOI":"10.21147\/j.issn.1000-9604.2019.01.10","article-title":"Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China","volume":"31","author":"Shi","year":"2019","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.immuni.2020.11.002_bib70","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.immuni.2019.12.007","article-title":"Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4+ T Cells","volume":"52","author":"\u015aledzi\u0144ska","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2020.11.002_bib71","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1101\/gad.9.9.1021","article-title":"A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome)","volume":"9","author":"Steimle","year":"1995","journal-title":"Genes Dev."},{"key":"10.1016\/j.immuni.2020.11.002_bib72","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1261\/rna.2192803","article-title":"Lentivirus-delivered stable gene silencing by RNAi in primary cells","volume":"9","author":"Stewart","year":"2003","journal-title":"RNA"},{"issue":"D1","key":"10.1016\/j.immuni.2020.11.002_bib73","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2020.11.002_bib74","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1609279","article-title":"T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer","volume":"375","author":"Tran","year":"2016","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2020.11.002_bib75","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1084\/jem.182.3.689","article-title":"A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma","volume":"182","author":"Van den Eynde","year":"1995","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.immuni.2020.11.002_bib76","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1840703","article-title":"A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma","volume":"254","author":"van der Bruggen","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.immuni.2020.11.002_bib77","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1016\/S0021-9258(19)84524-6","article-title":"The enzymatic synthesis of thymidylate. I. Early steps in the purification of thymidylate synthetase of Escherichia coli","volume":"237","author":"Wahba","year":"1962","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.immuni.2020.11.002_bib78","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1158\/0008-5472.CAN-17-2900","article-title":"HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes","volume":"78","author":"Wang","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.immuni.2020.11.002_bib79","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/978-1-4939-9151-8_16","article-title":"Protocols for CRISPR-Cas9 Screening in Lymphoma Cell Lines","volume":"1956","author":"Webster","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.immuni.2020.11.002_bib80","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the Tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"The Journal of Open Source Software"},{"key":"10.1016\/j.immuni.2020.11.002_bib81","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2020.11.002_bib82","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nature14001","article-title":"Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing","volume":"515","author":"Yadav","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2020.11.002_bib83","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccr.2012.05.024","article-title":"Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma","volume":"21","author":"Yang","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.immuni.2020.11.002_bib84","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1182\/blood-2010-11-321208","article-title":"Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation","volume":"117","author":"Yap","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.immuni.2020.11.002_bib85","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.it.2011.08.001","article-title":"DRiPs solidify: progress in understanding endogenous MHC class I antigen processing","volume":"32","author":"Yewdell","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1016\/j.immuni.2020.11.002_bib86","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.molcel.2010.05.010","article-title":"Structural basis for assembly of Hsp90-Sgt1-CHORD protein complexes: implications for chaperoning of NLR innate immunity receptors","volume":"39","author":"Zhang","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.immuni.2020.11.002_bib87","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1158\/1078-0432.CCR-19-1351","article-title":"Targeting EZH2 Enhances Antigen Presentation, Antitumor Immunity, and Circumvents Anti-PD-1 Resistance in Head and Neck Cancer","volume":"26","author":"Zhou","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.immuni.2020.11.002_bib88","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.celrep.2017.07.007","article-title":"The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy","volume":"20","author":"Zingg","year":"2017","journal-title":"Cell Rep."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761320304672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1074761320304672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:11:14Z","timestamp":1761034274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1074761320304672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1074761320304672"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2020.11.002","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.03.13.989558","asserted-by":"object"}]},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human Lymphomas","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2020.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2020.11.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}